PediaFlow® VAD
Development Partners
PediaFlow Consortium
The PediaFlow VAD is being developed by a multi-disciplinary and multi-institutional consortium.
The consortium members form a team with decades of experience and world-class accomplishments in the blood pump field. The members are:
 Pittsburgh, PA |
 Pittsburgh, PA |
 Goleta, CA |
 Salt Lake City, UT |
 Pittsburgh, PA |
 Pittsburgh, PA |
The PediaFlow® VAD Consortium is funded by a $4.5M contract from NIH. It is one of five such contracts awarded in the United States.
The Principal Investigator on the NIH Contract is Dr. Harvey Borovetz of the University of Pittsburgh. Dr. Borovetz is chairman of the Department of Bioengineering and is a faculty at the Department of Surgery at the University of Pittsburgh Medical Center (UPMC).
For further information on the PediaFlow® VAD, please visit the LaunchPoint Technologies website at: www.launchpnt.com/portfolio/pediaflow-vad.html.
Availability
-
WorldHeart's PediaFlow® VAD is not currently available for sale or investigational use.
Status
-
Since 2007, WorldHeart and its R&D consortium members for the PediaFlow® VAD have achieved several developmental milestones including acute and chronic animal trials with PediaFlow® VAD prototypes.